Transaction · 0001231589-26-000018

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 850.000000 shares for an estimated $444366.23. Reported holdings after the transaction were 46824.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeAug 21
Trade dateAug 20, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$513.12
Pre-filing
1mo ago +4.4%1w ago -2.3%1d ago +3.1%
Returns since
7d +0.5%30d +0.5%90d +0.5%180d +0.5%1y +0.5%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-08-21Filed 13 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001231589-26-000018
Common Stock
Transaction date
Aug 20, 2026
Filed Aug 21, 2026, 08:43 PM · 1d delay
Shares
850 sh
$52.2k per share
Estimated value
-$44.4M
Computed from shares × price
Holdings after
46.8k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $519.33 to $520.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $520.36 to $521.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  4. F4

    This transaction was executed in multiple trades at prices ranging from $521.39 to $522.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  5. F5

    This transaction was executed in multiple trades at prices ranging from $522.43 to $523.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  6. F6

    This transaction was executed in multiple trades at prices ranging from $523.45 to $523.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  7. F7

    This transaction was executed in multiple trades at prices ranging from $524.57 to $525.435. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  8. F8

    This transaction was executed in multiple trades at prices ranging from $526.145 to $526.625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pr…

Original filing · 0001231589-26-000018
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR